5‐HT<sub>6</sub> receptor antagonist SB‐271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex

Laurent Lacroix, Lee A. Dawson, Jim J. Hagan, Christian Heidbreder

Synapse · 2003 · 144 citations · 40 references

Concepts

Abstract

The present study investigated the neurochemical effects of the selective 5-HT(6) receptor antagonist SB-271046 in the rat medial prefrontal cortex (mPFC). The effect of SB-271046 on extracellular levels of dopamine (DA), norepinephrine (NE), and serotonin (5-HT) in the mPFC was examined using in vivo microdialysis in the freely moving rat. SB-271046 (10 mg/kg, p.o.) produced a significant increase in extracellular levels of both DA and NE without altering 5-HT neurotransmission. These results further support the rationale for the use of 5-HT(6) receptor antagonists in the treatment of cognitive dysfunction associated with psychiatric diseases.

References

40